SCHEMBL25935974

SCHEMBL25935974

CCc1ccc(-c2ccc(=O)[nH]n2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.69
LMNA P02545 3/20 0.66
MEN1 O00255 1/20 0.66
KMT2A Q03164 1/20 0.66
CYP1A2 P05177 2/20 0.59
CA12 O43570 1/20 0.54
ALPL P05186 1/20 0.54
CA9 Q16790 1/20 0.54
PDE3B Q13370 5/20 0.51
PDE3A Q14432 5/20 0.51
PDE4A P27815 3/20 0.51
PDE4B Q07343 3/20 0.51
PDE4C Q08493 3/20 0.51
PDE4D Q08499 3/20 0.51
HRH3 Q9Y5N1 5/20 0.51
NOTUM Q6P988 1/20 0.50
METAP2 P50579 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 2/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10353474 0.86 MAPT (0.80) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL3452908 0.84 LMNA (0.80) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL24732040 0.81 LMNA (0.60) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL9815929 0.81 MAPT (0.97) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL11035831 0.79 LMNA (1.00) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL7302713 0.79 MAPT (0.66) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL1640658 0.79 MAPT (0.66) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL10969675 0.78 LMNA (0.69) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL3109943 0.78 CYP1A2 (0.59) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL9687063 0.77 LMNA (0.69) MAPTLMNAMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 WO disclosed